Comparison of postoperative pain for 0.5% hyperbaric bupivacaine given as spinal block with intravenous or spinal dexmedetomidine in abdominal hysterectomy.
Not Applicable
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2022/05/042588
- Lead Sponsor
- JLN medical college and hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.body weight 40 to 80 kg.
2.Patient belonging to ASA class I and II.
3.Patient undergoing abdominal surgery.
Exclusion Criteria
1.Patient refusal or uncooperative patient.
2.Any known hypersensitivity or contraindication to bupivacaine, dexmedetomidine.
3.Local pathology at the site of injection or disability limiting the performance of spinal block.
History of convulsion, bleeding disorder, severe neurological deficit, thyroid disorder.
Patient with history of respiratory,cardiac,hepatic or renal disease.
Patient having a history of significant neurological,psychiatric or neuromuscular disorders.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Duration of analgesia.Timepoint: 1 year
- Secondary Outcome Measures
Name Time Method Onset and recovery(time to 2 segment regression) of sensory block. <br/ ><br>Onset and recovery of motor block, <br/ ><br>Peri operative sedation score. <br/ ><br>Haemodyanamic changes. <br/ ><br>Adverse effect if any.Timepoint: 1 year